InvestorsHub Logo
Followers 53
Posts 1776
Boards Moderated 0
Alias Born 03/22/2015

Re: DR Ryan post# 341410

Thursday, 08/13/2020 3:49:54 PM

Thursday, August 13, 2020 3:49:54 PM

Post# of 401721

And again, that is years ago. Let's focus on going forward. Crunching the numbers on dead drugs is pointless and goes nowhere.





LOL The opioids were dumped out the back door less than a year ago. And it's not like this was some old holdover Treppel plan he got stuck with. These applications were all from 2016 and after, not ancient history. The revenue (approximately $50M-$84M) would be recurring every year, including this year, next year, and all future years. It was a bad business decision to sit on them without commercializing, but dumping them permanently for less than Nasrat's hotel costs was a monumental act of negligence that deserves ongoing scrutiny of the motives involved and the long-term damage that was done.



And as for my focus going forward:


Here are my goals:

1. Ongoing oversight with an independent auditor for both Elite & Mikah who will guarantee that material events for Mikah are reported to Elite shareholders.

2. Establish the details of the Adderall Purchase Agreement between Mikah and SunGen, including and especially any partners or financing involved.

3. Establish a protocol for the transfer of the Adderall ANDA's from Mikah to Elite and immediately begin the protocol.





Everyone is welcome to join me in expecting better from Elite management.




Occam's razor: the simplest solution is most likely the right one.

Hanlon's razor: never attribute to malice that which is adequately explained by stupidity.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News